Today: 16 July 2026
JPMorgan Chase (NYSE: JPM) Guidance Trade-Off Tests Its Valuation Premium
16 July 2026
1 min read

JPMorgan Chase (NYSE: JPM) Guidance Trade-Off Tests Its Valuation Premium

NEW YORK, July 16, 2026, 11:24 EDT

  • U.S. cash trading was open; JPM last traded at $346.32, down 0.2%.
  • JPM raised its 2026 interest-income and adjusted-expense forecasts by $2.5 billion each.
  • The stock trades near 3.1 times tangible book, well above major bank peers.

JPMorgan Chase (NYSE: JPM) shares edged lower on Thursday. Its higher interest-income outlook arrived with an equal expense increase. Both revisions were $2.5 billion.

That arithmetic removes an automatic earnings lift from the guidance change. Investors now need fees and trading gains to outrun the cost base.

The test matters because JPM carries a steep valuation premium. Return on tangible common equity, or ROTCE, anchors that comparison.

CompanyLatest priceSession moveSecond-quarter ROTCEPrice/tangible book
JPMorgan Chase (NYSE: JPM)$346.32-0.2%23.0%, adjusted3.1x
Bank of America (NYSE: BAC)$61.81+0.4%17.0%2.1x
Citigroup (NYSE: C)$133.76-0.8%13.0%1.3x

JPM’s ROTCE excludes significant items. Peer figures are reported. Multiples use latest prices and June 30 tangible book values.

JPM’s multiple is about 45% above Bank of America’s. It is roughly 130% above Citigroup’s. The corresponding ROTCE gaps are smaller, suggesting investors pay extra for durability.

Reported profit reached a record $21.2 billion. Excluding significant items, net income was $16.9 billion. A $4.6 billion gain tied to Visa (NYSE: V) shares was the largest adjustment.

The recurring engine remained solid. Average loans rose 10%. Non-markets interest income increased 4% to $23.7 billion. Card loss guidance improved to 3.2% from 3.4%.

Operating leverage appeared inside the commercial and investment bank. Revenue rose 27%, against an 18% expense increase. Markets revenue climbed 35%, while equity-markets revenue jumped 86%.

“The biggest beats were coming from investment banking, capital markets, and trading,” said Neville Javeri, a portfolio manager at Allspring Global Investments. That mix is powerful. It is also cyclical. Reuters

JPM now forecasts 2026 net interest income near $105.5 billion. The prior outlook was $103 billion. Adjusted expenses are now seen near $107.5 billion, up from $105 billion.

Chief Executive Jamie Dimon called markets healthy, active and exuberant. Then he added: “We just don’t know how long it will continue.” The caution fits the valuation math. Reuters

Risks: Trading volumes can fade quickly. A deal slowdown would expose the higher cost base. Sticky inflation could also pressure credit and funding costs.

For investors, the next catalyst is not another record headline. It is evidence that revenue growth can remain ahead of expenses. Until then, JPM’s premium rests on execution.

Michał Rogucki is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic developments. A graduate of Humboldt University of Berlin, he previously worked in investment research and market analysis before transitioning to financial journalism. He covers the trends and events that matter most to investors worldwide.

Stock Market Today

  • IHI jumps as medtech rallies; PTF down on tech weakness
    July 16, 2026, 1:07 PM EDT. The iShares U.S. Medical Devices ETF (IHI) is up about 5% Thursday, with Abbott Laboratories gaining 11.7% and Tandem Diabetes Care up 8.2%. Invesco Dorsey Wright Technology Momentum ETF (PTF) is off around 5.5%, weighed by losses in AXTI (-12.7%) and Sandisk (-9.8%). Sector moves track market volatility.
ASML Holding (NASDAQ: ASML) steady after outlook sets €14.4B Q4 bar
Previous Story

ASML Holding (NASDAQ: ASML) steady after outlook sets €14.4B Q4 bar

US Stocks Open Mixed With Tech Under Pressure
Next Story

US Stocks Open Mixed With Tech Under Pressure

Go toTop